Supply Chains to Admire 2023 - Report v4.0

24

24

SUPPLY CHAINS TO ADMIRE | 2023

Drug Retail

In 2023, there are no drug retail supply chains to Admire Winners. Prior award winners included CVS and Sun Drug. Companies subconsciously traded margin for cash. Over the last decade, the overall industry performance declined. When we compare 2013 to 2022, we find that the operating margins are flat while inventory turns declined by 20%.

Table 11. Drug Retail Sector Averages for the Period of 2013-2022

INDUSTRY: Retail Broadline

IMPROVE- MENT

COMPANY INFORMATION

PERFORMANCE

VALUE

RETURN ON INVESTED CAPITAL

2022 REVENUE (MS)

SUPPLY CHAIN INDEX

GROWTH (Year Over Year Revenue)

FUNDAMENTAL AVERAGE SCORE

INVENTORY TURNS

OPERATING MARGIN

PRICE TO BOOK

MARKET CAP

NAME

2013 - 2022

CVS Pharmacy

322,467

1

10.4%

10.96

5.5%

6.5%

9

2.03

98,937

PetMed Express

273

3

1.6%

6.99

13.0%

25.0%

8

4.60

489

Raia Drogasil

5,637

1

5.7%

3.76

5.1%

11.2%

8

5.55

5,071

Rite-Aid Pharmacy

24,568

5

-0.2%

8.18

1.4%

4.2%

NA

3.69

3,474

Sundrug Company Ltd

5,779

7

1.9%

6.65

6.1%

14.9%

9

1.99

2,812

Ulta Beauty Inc

8,631

4

18.0%

3.58

12.3%

29.5%

8

8.97

14,707

Walgreens Boots Alliance

132,703

5

6.9%

10.29

3.6%

9.0%

9

2.48

60,813

MEAN WITH OUTLIERS

71,437

6.3%

7.20

6.7%

14.3%

8.6

4.18

26,615

MEAN WITHOUT OUTLIERS

6.3%

7.20

6.7%

14.3%

8.5

4.18

26,615

Made with FlippingBook interactive PDF creator